Sapience Investments’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18K | Sell |
1,914
-45,468
| -96% | -$499K | 2.34% | 7 |
|
|
2025
Q4 | $588K | Buy |
47,382
+7,385
| +18% | +$98.2K | 2.22% | 21 |
|
|
2025
Q3 | $573K | Sell |
39,997
-178,995
| -82% | -$2.45M | 2.25% | 16 |
|
|
2025
Q2 | $2.69M | Buy |
218,992
+76,170
| +53% | +$1.11M | 1.79% | 16 |
|
|
2025
Q1 | $3.14M | Sell |
142,822
-21,953
| -13% | -$516K | 2.24% | 3 |
|
|
2024
Q4 | $3.74M | Buy |
164,775
+24,830
| +18% | +$542K | 2.18% | 6 |
|
|
2024
Q3 | $2.54M | Sell |
139,945
-260
| -0.2% | -$6.03K | 1.26% | 37 |
|
|
2024
Q2 | $4.09M | Sell |
140,205
-15,592
| -10% | -$462K | 2.09% | 6 |
|
|
2024
Q1 | $5.52M | Sell |
155,797
-75,340
| -33% | -$3.01M | 1.83% | 15 |
|
|
2023
Q4 | $10.1M | Sell |
231,137
-14,563
| -6% | -$573K | 2.4% | 6 |
|
|
2023
Q3 | $9.38M | Buy |
245,700
+21,481
| +10% | +$904K | 2.26% | 12 |
|
|
2023
Q2 | $9.22M | Buy |
224,219
+31,650
| +16% | +$1.52M | 2.07% | 13 |
|
|
2023
Q1 | $11.1M | Sell |
192,569
-11,280
| -6% | -$636K | 2.56% | 8 |
|
|
2022
Q4 | $11.4M | Sell |
203,849
-53,250
| -21% | -$2.71M | 2.4% | 7 |
|
|
2022
Q3 | $10.9M | Buy |
257,099
+92,010
| +56% | +$4.71M | 2.29% | 6 |
|
|
2022
Q2 | $8.92M | Sell |
165,089
-32,351
| -16% | -$1.94M | 1.67% | 23 |
|
|
2022
Q1 | $12.7M | Sell |
197,440
-7,950
| -4% | -$523K | 1.54% | 25 |
|
|
2021
Q4 | $13.8M | Buy |
205,390
+27,785
| +16% | +$1.88M | 1.57% | 29 |
|
|
2021
Q3 | $12.2M | Buy |
177,605
+15,945
| +10% | +$1.13M | 1.44% | 35 |
|
|
2021
Q2 | $11M | Sell |
161,660
-7,665
| -5% | -$542K | 1.37% | 34 |
|
|
2021
Q1 | $11.7M | Sell |
169,325
-79,310
| -32% | -$5.37M | 1.47% | 32 |
|
|
2020
Q4 | $16.1M | Sell |
248,635
-18,280
| -7% | -$984K | 2.24% | 7 |
|
|
2020
Q3 | $12.6M | Buy |
266,915
+54,210
| +25% | +$2.58M | 2.24% | 5 |
|
|
2020
Q2 | $9.99M | Sell |
212,705
-60,355
| -22% | -$2.97M | 1.84% | 13 |
|
|
2020
Q1 | $12.2M | Buy |
273,060
+18,830
| +7% | +$988K | 2.71% | 1 |
|
|
2019
Q4 | $14.8M | Buy |
254,230
+90,720
| +55% | +$5.4M | 2.07% | 12 |
|
|
2019
Q3 | $9.82M | Sell |
163,510
-300
| -0.2% | -$17.9K | 1.37% | 27 |
|
|
2019
Q2 | $9.15M | Buy |
163,810
+31,000
| +23% | +$1.6M | 1.25% | 30 |
|
|
2019
Q1 | $7.4M | Buy |
+132,810
| New | +$6.76M | 0.98% | 43 |
|
|
2017
Q1 | – | Sell |
-70,400
| Closed | -$3.02M | – | 86 |
|
|
2016
Q4 | $3.02M | Buy |
+70,400
| New | +$2.86M | 0.93% | 61 |
|
Other funds holding IART
RCMNY
PCMI
Sapience Investments's IART Position: Q1 2026 in Review
Sapience Investments reduced its Integra LifeSciences (IART) stake by 96% in Q1 2026, selling an estimated $499K and leaving 1,914 shares worth $18K. The position accounts for 2.34% of the portfolio, ranked #7.
Sapience Investments first reported a position in IART in Q4 2016 and has held it in 30 quarters since. The position peaked at $16.1M in Q4 2020. 202 funds tracked by Wall St. Rank hold IART as of Q1 2026.
- Sapience Investments held 1,914 shares of Integra LifeSciences worth $18K as of Q1 2026.
- Sapience Investments sold 45,468 Integra LifeSciences shares in Q1 2026, an estimated $499K.
- Integra LifeSciences made up 2.34% of Sapience Investments's portfolio in Q1 2026, its #7 holding.
- Sapience Investments first reported a position in Integra LifeSciences in Q4 2016 and has held it in 30 quarters since.
- Sapience Investments's Integra LifeSciences position peaked at $16.1M in Q4 2020.
- 202 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.
Based on Sapience Investments's 13F filing for Q1 2026, filed 15 May 2026.